Uttroside B, a US-FDA-Designated Orphan Drug Against Hepatocellular Carcinoma (HCC), Impedes Non-alcoholic Steatohepatitis (NASH) and NASH -Induced HCC
Tennyson Prakash Rayginia, Chenicheri Kizhakkeveettil Keerthana, Sreekumar Usha Devi Aiswarya, Sadiq Chembothumparambil Shifana, Somaraj Jannet, Sanjay Suresh Varma, Joy P Maria, Mundanattu Swetha, Archana Payickattu Retnakumari, Lekshmi R. Nath, Kalimuthu Kalishwaralal, Vishnu Sunil Jaikumar, Sankar Sundaram, Nikhil Ponnoor Anto, Noah Isakov, , Ruby John Anto
This study demonstrates that Uttroside B alleviates NASH and prevents its progression to HCC in mouse models.
bioRxiv · Nov 6, 2024 · PreprintCancer Biology